Execution Summary
- Study: Study 19: Oncology Cohort
- Owner: Eve Patel
- Status: planned
- Started: 2025-10-18T00:00:00.000Z
- Samples: 5
- Assay runs: 6 (5 open)
Experiment EX-0592
Hide
Execution notebook with protocol context, sample traceability, run outcomes, and downstream readiness checks. Business and scientific purpose: improve experimental quality, reproducibility, and cycle time from design to validated evidence. Experiment EX-0592 is connected to linked entities, metrics, and workflow actions in this workspace. Use these panels to review evidence, identify risks, and decide the next best scientific action. The view uses deterministic demo data shaped to mirror realistic drug discovery operations.
Protocol Context
- Protocol: Cell Prep 16
- Version: v1.9
- Effective date: 2025-09-25T00:00:00.000Z
- Signed by: Daniel Osei